Detalhe da pesquisa
1.
EGR1-mediated metabolic reprogramming to oxidative phosphorylation contributes to ibrutinib resistance in B-cell lymphoma.
Blood
; 142(22): 1879-1894, 2023 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37738652
2.
Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma.
Blood
; 139(10): 1541-1556, 2022 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34818414
3.
Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice.
Blood
; 133(3): 266-279, 2019 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30514750
4.
Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation.
Proc Natl Acad Sci U S A
; 115(7): 1582-1587, 2018 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29382747
5.
Stabilization of Foxp3 by Targeting JAK2 Enhances Efficacy of CD8 Induced Regulatory T Cells in the Prevention of Graft-versus-Host Disease.
J Immunol
; 201(9): 2812-2823, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30242073
6.
Dendritic cell-mediated immune humanization of mice: implications for allogeneic and xenogeneic stem cell transplantation.
J Immunol
; 192(10): 4636-47, 2014 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24740501
7.
Generation of lentivirus-induced dendritic cells under GMP-compliant conditions for adaptive immune reconstitution against cytomegalovirus after stem cell transplantation.
J Transl Med
; 13: 240, 2015 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-26198406
8.
A very long-acting IL-15: implications for the immunotherapy of cancer.
J Immunother Cancer
; 10(1)2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35101947
9.
Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphoma.
Blood Adv
; 6(7): 2346-2360, 2022 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35030628
10.
Enhanced efficacy of JAK1 inhibitor with mTORC1/C2 targeting in smoldering/chronic adult T cell leukemia.
Transl Oncol
; 14(1): 100913, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33129109
11.
EGR1 Addiction in Diffuse Large B-cell Lymphoma.
Mol Cancer Res
; 19(8): 1258-1269, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33980611
12.
Targeting the Complement Alternative Pathway Permits Graft Versus Leukemia Activity while Preventing Graft Versus Host Disease.
Clin Cancer Res
; 26(13): 3481-3490, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31919135
13.
Vitamin C stabilizes CD8+ iTregs and enhances their therapeutic potential in controlling murine GVHD and leukemia relapse.
Blood Adv
; 3(24): 4187-4201, 2019 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31856270
14.
Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response.
Clin Cancer Res
; 25(3): 1036-1049, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30327305
15.
Thioredoxin-1 confines T cell alloresponse and pathogenicity in graft-versus-host disease.
J Clin Invest
; 129(7): 2760-2774, 2019 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31045571
16.
IL-27 Receptor Signaling on T cells Augments GVHD Severity through Enhancing Th1 Responses.
J Immunol Res Ther
; 3(1): 151-157, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30906912
17.
Inducible T-Cell Co-Stimulator Impacts Chronic Graft-Versus-Host Disease by Regulating Both Pathogenic and Regulatory T Cells.
Front Immunol
; 9: 1461, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29988391
18.
PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity.
J Clin Invest
; 128(7): 2787-2801, 2018 07 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29781812
19.
Complement C3a and C5a receptors promote GVHD by suppressing mitophagy in recipient dendritic cells.
JCI Insight
; 3(24)2018 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30568037
20.
CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response.
Cell Metab
; 27(1): 85-100.e8, 2018 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29129787